These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 12208248)
1. Basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in vitreous fluid from eyes with retinal detachment complicated by proliferative vitreoretinopathy. La Heij EC; van de Waarenburg MP; Blaauwgeers HG; Kessels AG; Liem AT; Theunissen C; Steinbusch H; Hendrikse F Am J Ophthalmol; 2002 Sep; 134(3):367-75. PubMed ID: 12208248 [TBL] [Abstract][Full Text] [Related]
2. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Kon CH; Occleston NL; Aylward GW; Khaw PT Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974 [TBL] [Abstract][Full Text] [Related]
3. Levels of basic fibroblast growth factor, glutamine synthetase, and interleukin-6 in subretinal fluid from patients with retinal detachment. La Heij EC; Van De Waarenburg MP; Blaauwgeers HG; Kessels AG; De Vente J; Liem AT; Steinbusch H; Hendrikse F Am J Ophthalmol; 2001 Oct; 132(4):544-50. PubMed ID: 11589877 [TBL] [Abstract][Full Text] [Related]
5. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of RAGE and its ligands in proliferative retinal disease. Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297 [TBL] [Abstract][Full Text] [Related]
7. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691 [TBL] [Abstract][Full Text] [Related]
8. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114 [TBL] [Abstract][Full Text] [Related]
9. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Cassidy L; Barry P; Shaw C; Duffy J; Kennedy S Br J Ophthalmol; 1998 Feb; 82(2):181-5. PubMed ID: 9613386 [TBL] [Abstract][Full Text] [Related]
10. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade. Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment. Symeonidis C; Rotsos T; Matsou A; Dermenoudi M; Georgalas I; Tsinopoulos I; Makri O; Souliou E; Dimitrakos SA Ocul Immunol Inflamm; 2021 Feb; 29(2):355-361. PubMed ID: 31661651 [No Abstract] [Full Text] [Related]
12. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070 [TBL] [Abstract][Full Text] [Related]
13. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders. Abu el-Asrar AM; Van Damme J; Put W; Veckeneer M; Dralands L; Billiau A; Missotten L Am J Ophthalmol; 1997 May; 123(5):599-606. PubMed ID: 9152065 [TBL] [Abstract][Full Text] [Related]
14. The role of thrombin in proliferative vitreoretinopathy. Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355 [TBL] [Abstract][Full Text] [Related]
15. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment. Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940 [TBL] [Abstract][Full Text] [Related]
16. Quantitative study of basic fibroblast growth factor in vitreous with proliferative vitreoretinopathy. Liang X; Li C; Gao R; Ding X; Tang S; Xie C; Li S Yan Ke Xue Bao; 2000 Mar; 16(1):7-10. PubMed ID: 12579721 [TBL] [Abstract][Full Text] [Related]
18. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911 [TBL] [Abstract][Full Text] [Related]
19. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy. Mitamura Y; Takeuchi S; Ohtsuka K; Matsuda A; Yamamoto T; Yamamoto S; Hiraiwa N; Kusakabe M Ophthalmologica; 2003; 217(6):422-5. PubMed ID: 14573976 [TBL] [Abstract][Full Text] [Related]
20. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment. Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]